Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Guerci

Showing results (21-30 of 113) with videos related to

Pageof 12
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 10, 2019
Lack of Treatment Persistence and Treatment Nonadherence as Barriers to Glycaemic Control in Patients with Type 2 DiabetesBruno Guerci, Neha Chanan, Simarjeet Kaur, et al.
Diabetes, Obesity & Metabolism|December 7, 2018
Predictive factors associated with three years of response to HbA1c goals with exenatide QW or insulin glargine: Post-hoc analysis of the DURATION-3 studyBruno Guerci, Michael E Trautmann, Tim Lin, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|July 25, 2017
[Self-monitoring of blood glucose in France: data from a national survey]Bruno Guerci, Pierre-Yves Benhamou, Danièle Durain, et al.
Annales D'Endocrinologie|January 16, 2025
Gonadotropic axis following endoscopic surgery for pituitary neuroendocrine tumor in patients of reproductive ageGeorge Riley, Léa Demarquet, Bruno Guerci, et al.
Diabetes Care|March 1, 2003
Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogsBruno Guerci, Michèle Floriot, Philip Böhme, et al.
Diabetes Care|February 26, 2015
Erratum: efficacy and safety of dulaglutide versus sitagliptin after 52 weeks in type 2 diabetes in a randomized controlled trial (AWARD-5). Diabetes Care 2014;37:2149-2158Michael Nauck, Ruth S Weinstock, Guillermo E Umpierrez, et al.
Diabetes, Obesity & Metabolism|September 10, 2025
Hypoglycemia incidence and behavioural adjustments during free-living unstructured physical activity in adults with type 1 diabetes using AID systems: Results from the RAPPID studyMichael Joubert, Laurent Meyer, Said Bekka, et al.
Frontiers in Endocrinology|January 26, 2024
Prognostic indicators in pituitary adenoma surgery: a comprehensive analysis of surgical outcomes and complicationsGeorge Riley, Nicolas Scheyer, Marc Klein, et al.
Diabetes Care|March 29, 2003
Accuracy of an electrochemical sensor for measuring capillary blood ketones by fingerstick samples during metabolic deterioration after continuous subcutaneous insulin infusion interruption in type 1 diabetic patientsBruno Guerci, Muriel Benichou, Michèle Floriot, et al.
Diabetes Care|April 19, 2014
Efficacy and safety of dulaglutide versus sitagliptin after 52 weeks in type 2 diabetes in a randomized controlled trial (AWARD-5)Michael Nauck, Ruth S Weinstock, Guillermo E Umpierrez, et al.
Pageof 12

Showing results (21-30 of 113) with videos related to

Sort By:
Pageof 12
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 10, 2019
Lack of Treatment Persistence and Treatment Nonadherence as Barriers to Glycaemic Control in Patients with Type 2 DiabetesBruno Guerci, Neha Chanan, Simarjeet Kaur, et al.
Diabetes, Obesity & Metabolism|December 7, 2018
Predictive factors associated with three years of response to HbA1c goals with exenatide QW or insulin glargine: Post-hoc analysis of the DURATION-3 studyBruno Guerci, Michael E Trautmann, Tim Lin, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|July 25, 2017
[Self-monitoring of blood glucose in France: data from a national survey]Bruno Guerci, Pierre-Yves Benhamou, Danièle Durain, et al.
Annales D'Endocrinologie|January 16, 2025
Gonadotropic axis following endoscopic surgery for pituitary neuroendocrine tumor in patients of reproductive ageGeorge Riley, Léa Demarquet, Bruno Guerci, et al.
Diabetes Care|March 1, 2003
Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogsBruno Guerci, Michèle Floriot, Philip Böhme, et al.
Diabetes Care|February 26, 2015
Erratum: efficacy and safety of dulaglutide versus sitagliptin after 52 weeks in type 2 diabetes in a randomized controlled trial (AWARD-5). Diabetes Care 2014;37:2149-2158Michael Nauck, Ruth S Weinstock, Guillermo E Umpierrez, et al.
Diabetes, Obesity & Metabolism|September 10, 2025
Hypoglycemia incidence and behavioural adjustments during free-living unstructured physical activity in adults with type 1 diabetes using AID systems: Results from the RAPPID studyMichael Joubert, Laurent Meyer, Said Bekka, et al.
Frontiers in Endocrinology|January 26, 2024
Prognostic indicators in pituitary adenoma surgery: a comprehensive analysis of surgical outcomes and complicationsGeorge Riley, Nicolas Scheyer, Marc Klein, et al.
Diabetes Care|March 29, 2003
Accuracy of an electrochemical sensor for measuring capillary blood ketones by fingerstick samples during metabolic deterioration after continuous subcutaneous insulin infusion interruption in type 1 diabetic patientsBruno Guerci, Muriel Benichou, Michèle Floriot, et al.
Diabetes Care|April 19, 2014
Efficacy and safety of dulaglutide versus sitagliptin after 52 weeks in type 2 diabetes in a randomized controlled trial (AWARD-5)Michael Nauck, Ruth S Weinstock, Guillermo E Umpierrez, et al.
Pageof 12